2008
H. N. Sen, Buggage, R., Hammel, K., Levy-Clarke, G., and Nussenblatt, R.,
“Infliximab for the Treatment of Scleritis and Recalcitrant Uveitis”, 2008.
2003
R. Nussenblatt, Li, Z., Robinson, R., Shames, R., Tang, M., Mailman, M., Thompson, D., Peterson, J., Sen, H., Al-Khatib, S., Ursea, R., Srivastava, S., Bamji, A., Sran, P., Waldmann, T., and Buggage, R.,
“Daclizumab therapy in Uveitis patients: Preliminary safety and activity data for establishing parameters for subcutaneous administration for long term therapy”, 2003.
R. Buggage, Thompson, D., Sen, H., Al-Khatib, S., Srivastava, S., Ursea, R., Bamji, A., Waldmann, T., and Nussenblatt, R.,
“A masked randomized study to investigate the safety and efficacy of Daclizumab for treatment of Ocular Behcet’s Disease”, 2003.
R. Buggage, Thompson, D., Sen, H., Al-Khatib, S., Srivastava, S., Ursea, R., Bamji, A., Waldmann, T., and Nussenblatt, R.,
“A Study to investigate the Safety and Efficacy of Daclizumab to treat the ocular complications related to the Behcet’s disease”, 2003.
2002
R. N. Nussenblatt, Buggage, R., Thompson, D., Zhuqing, L., Ragheb, J., and Waldmann, T.,
“4 Year Daclizumab Therapy for Sight Threatening Uveitis”, 2002.
]